Cargando…
Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway
The insulin-like growth factor-1 receptor (IGF1R) has been identified as a potent anti-apoptotic, pro-survival tyrosine kinase-containing receptor. Overexpression of the IGF1R gene constitutes a typical feature of most human cancers. Consistent with these biological roles, cells expressing high leve...
Autores principales: | Werner, Haim, Meisel-Sharon, Shilhav, Bruchim, Ilan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817802/ https://www.ncbi.nlm.nih.gov/pubmed/29455671 http://dx.doi.org/10.1186/s12943-018-0807-z |
Ejemplares similares
-
The Role of the Insulin-Like Growth Factor 1 Pathway in Immune Tumor Microenvironment and Its Clinical Ramifications in Gynecologic Malignancies
por: Yahya, Muna Alemi, et al.
Publicado: (2018) -
TMPRSS2-ERG fusion protein regulates insulin-like growth factor-1 receptor (IGF1R) gene expression in prostate cancer: involvement of transcription factor Sp1
por: Sharon, Shilhav Meisel, et al.
Publicado: (2016) -
The Mechanism of Action of the Histone Deacetylase Inhibitor Vorinostat Involves Interaction with the Insulin-Like Growth Factor Signaling Pathway
por: Sarfstein, Rive, et al.
Publicado: (2011) -
Insulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection Pathways
por: Werner, Haim, et al.
Publicado: (2016) -
ZYG11A Is Expressed in Epithelial Ovarian Cancer and Correlates With Low Grade Disease
por: Achlaug, Laris, et al.
Publicado: (2021)